Effects of chronic renal failure on plasma clearance of insulin-like growth factor I, des-(1-3)IGF-I, and LR3IGF-I

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 4 34-4, 1996, Pages

  Gillespie, C M ^b   Hazel, S J ^b   Walton, P E ^b   Martin, A A ^a  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^b NONE

Author keywords

insulin like growth factor I analogues; insulin like growth factor I binding proteins; insulin like growth factor pharmacokinetics; organ distribution of insulin like growth factors

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HALF LIFE TIME; KIDNEY CLEARANCE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0029909218     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.4.e649     Document Type: Article

References (30)

1. Arany, E., P. Zabel, D. Freeman, and D. J. Hill. Elimination of radiolabelled recombinant human insulin-like growth factor binding protein-3 from the circulation, and its distribution amongst organs and tissues in adult male rats. Regul. Pept. 48: 133-143, 1993.
2. Ballard, F. J., S. E. Knowles, P. E. Walton, K. Edson, P. C. Owens, M. A. Mohler, and B. L. Ferraiolo. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I, IGF-II and des(1-3)IGF-I in rats. J. Endocrinol. 128: 197-204, 1991.
3. Bar, R. S., M. Boes, B. L. Dake, A. Sandra, B. M, M. Cascieri, and B. A. Booth. Tissue localization of perfused endothelial cell IGP binding protein is markedly altered by association with IGF-I. Endocrinology 127: 3243-3245, 1990.
4. 3IGF-I in pregnant rats. J. Endocrinol. 138: 327-336, 1993.
5. Baxter, R. C. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr. Scand. Suppl. 372: 107-114, 1991.
6. Blum, W. F., M. B. Ranke, K. Kietzmann, B. Tönshoff, and O. Mehls. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr. Nephrol. 5: 539-544, 1991.
7. De Mellow, J. S. M., and R. C. Baxter. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 156: 199-204, 1988.
8. Elgin, R. G., W. H. Busby, and D. R. Clemmons. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA 84: 3254-3258, 1987.
9. Fawcett, J., and R. Rabkin. The processing of insulin-like growth factor-I (IGF-I) by a cultured kidney cell line is altered by IGF-binding protein-3. Endocrinology 136: 1340-1347, 1995.
10. Fouque, D., S. C. Peng, and J. D. Kopple. Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int. 47: 869-875, 1995.
11. Francis, G. L., M. Ross, F. J. Ballard, S. J. Milner, C. Senn, K. M. McNeil, J. C. Wallace, R. King, and J. R. E. Wells. Novel recombinant fusion-protein analogues of insulin-like growth factor (IGF) -I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J. Mol. Endocrinol. 8: 213-223, 1992.
12. Hazel, S. J., C. M. Gillespie, R. J. Moore R. G. Clark, K. F. Jureidini, and A. A. Martin. Enhanced body growth in uremic rats treated with IGF-I and GH in combination. Kidney Int. 46: 58-68, 1994.
13. Hossenlopp, P., B. Segovia, C. Lassarre, M. Roghani, M. Bredon, and M. Binoux. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J. Clin. Endocrinol. Metab. 71: 797-805, 1990.
14. Lee, D. Y., S. K. Park, P. D. Yorgin, P. Cohen, Y. M. Oh, and R. G. Rosenfeld. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J. Clin. Endocrinol. Metab. 79: 1376-1382, 1994.
15. Lee, P. D. K., R. L. Hintz, J. B. Sperry, R. C. Baxter, and D. R. Powell. IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr. Res. 26: 308-315, 1989.
16. Lewitt, M. S., H. Saunders, and R. C. Baxter. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 133: 1797-1802, 1993.
17. Lewitt, M. S., H. Saunders, G. J. Cooney, and R. C. Baxter. Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. J. Endocrinol. 136: 253-260, 1993.
18. Martin, A. A., C. M. Gillespie, L. Moore, F. J. Ballard, and L. C. Read. Effects of insulin-like growth factor-I peptides in rats with acute renal failure. J. Endocrinol. 140: 23-32, 1993.
19. Martin, A. A., F. M. Tomas, S. E. Knowles, P. C. Owens, F. J. Ballard, and L. C. Read. IGF-I and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F626-F633, 1991.
20. Mehls, O., E. Ritz, E. B. Hunziker, P. Eggli, U. Heinrich, and J. Zapf. Improvement of growth and food utilization by human recombinant growth hormone in uraemia. Kidney Int. 33: 45-52, 1988.
21. Mehls, O., B. Tönshoff, W. F. Blum, U. Heinrich, and C. Seidel. Growth hormone and insulin-like growth factor I in chronic renal failure - pathophysiology and rationale for growth hormone treatment. Acta Paediatr. Scand. 370: 28-34, 1990.
22. Nakano, M., G. Kainer, J. W. Foreman, D. Ko, and J. C. M. Chan. The effects of exogenous rat growth hormone therapy on growth of uraemic rats fed an 8% protein diet. Pediatr. Res. 26: 204-207, 1989.
23. Poletti, L. F., R. J. Krieg, F. Santos, K. Niimi, J. D. Hanna, and J. C. M. Chan. Growth hormone secretory capacity of individual somatotropes in rats with chronic renal insufficiency. Pediatr. Res. 31: 528-531, 1992.
24. Powell, D. R., F. Liu, B. Baker, P. D. K. Lee, C. W. Belsha, E. D. Brewer, and R. L. Hintz. Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr. Res. 33: 136-143, 1993.
25. Powell, D. R., R. G. Rosenfeld, J. B. Sperry, B. K. Baker, and R. L. Hintz. Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am. J. Kidney Dis. 10: 287-292, 1987.
26. Rechler, M. M. Insulin-like growth factor binding proteins. Vitam. Horm. 47: 1-114, 1993.
27. Rowland, M., and T. N. Tozer. Clinical Pharmacokinetics: Concepts and Applications. Philadelphia, PA: Lea & Febiger, 1989.
28. 125I-labeled IGF-I in protein-restricted rats. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E406-E411, 1992.
29. Van Obberghen-Schilling, E., and J. Pouyssegur. Mitogen-potentiating action and binding characteristics of insulin and insulin-like growth factors in Chinese hamster fibroblasts. Exp. Cell Res. 147: 369-378, 1983.
30. Young, S. C. J., M. V. Miles, and D. R. Clemmons. Determination of the pharmacokinetic profiles of insulin-like growth factor binding protein-1 and protein-2 in rats. Endocrinology 131: 1867-1873, 1992.